Bull's Eye: Short Infosys, ICICI Bank; buy Sun Pharma

21001 Investors following Sun Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Bull's Eye: Short Infosys, ICICI Bank; buy Sun Pharma

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Markets Midday on CNBC-TV18 Watch the full show » ALSO READ See what other Experts & Brokerages are saying about Sun Pharma See messages about Sun Pharma

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Remember these are midcap ideas not just for the day, but stocks that look attractive in the medium-term as well.

This week, Ashish Kapur, Investshoppe, Lancelot D'Cunha, Sharvans Wealth Mgmt and Madhumita Ghosh, UNICON battle it out for top honours.

Below their top stock picks and analysis:

Ashish Kapur, Investshoppe

The first call for the day is a long position on Sun Pharma . We quiet like this company mainly because of very strong balance sheet, which the company has. There is very comfortable cash reserve. Also the company has been doing very well over the last few quarters mainly on account of a good traction in international sales. Their focus on exports along with acquisition of taro is really helping them; sustain their margins as well as revenue growth. We expect this trend to continue. For the day we have a target at Rs 540 with a stop loss of Rs 514.

Second call for the day is a long position on Venkys with a stop loss at Rs 420 and a target at Rs 445. We quiet like this company because it has been performing very well over the last few quarters. The poultry industry in India is said to do very well over the next few years. They plan to open number of new outlets in the coming few quarters. So as new outlets roll, the revenue growth from these outlets is going to add to the profitability of this company. Overall the company is available at a very decent valuation.

My third call for the day is a long position on Crompton Greaves . Fundamentally it is a very good stock available at very cheap valuations. This is a very good opportunity for long term investors to get into the stock. With the market in the pull back rally we expect momentum to continue in Crompton Greaves. For the day we have a target at Rs 140 with a stop loss at Rs 128.

My final call for the day is a short position on BHEL with a target at Rs 250 and a stop loss at Rs 267. This is mainly to hedge the portfolio because we feel that after the good run up over the last couple of days the market could face some tough weather going forward. Capital goods is one space where the margin pressure is very evident and likely to continue for sometime. So fair to assume that if the market does weaken today BHEL would face pressure.